Figure legends
Figure 1 Prevalence of IDH1/IDH2 mutations in 28,868 patients with pan-cancer.
Figure 2 Top 20 significantly mutated genes in IDH1/2mutated patients of biliary tract cancer (A), liver cancer (B), lung cancer (C), colorectal cancer (D) and gastric cancer (E). Genes were ranked by mutation frequencies (right panel). Age and gender are annotated in the top panel. Tumor mutational load among IDH1/2mutated pan-cancers (F) and in biliary tract cancer (G).